↓ Skip to main content

Follow-up of phase I trial of adalimumab and rosiglitazone in FSGS: III. Report of the FONT study group

Overview of attention for article published in BMC Nephrology, January 2010
Altmetric Badge

Mentioned by

twitter
3 X users

Citations

dimensions_citation
33 Dimensions

Readers on

mendeley
28 Mendeley